| Literature DB >> 35250794 |
Zhonghao Wang1, Binbin Zhu1, Licheng Fu1, Jianhua Yan1.
Abstract
PURPOSE: To provide a new classification system for diplopia and evaluate the etiology and clinical features of diplopia subtypes in south China.Entities:
Keywords: cranial nerve palsy; diplopia; extraocular muscles; nasopharyngeal carcinoma; orbital diseases
Year: 2022 PMID: 35250794 PMCID: PMC8889929 DOI: 10.3389/fneur.2021.805253
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Classification and etiologies of patients with diplopia.
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total, | 303 (100) | 58 (19.1) | 50 (16.5) | 49 (16.2) | 70 (23.1) | 28 (9.2) | 14 (4.6) | 12 (4.0) | 2 (0.7) | 9 (3.0) | 11 (3.6) |
| sEOM, | 158 (52.1) | 2 (1.3) | 26 (16.4) | 42 (26.6) | 41 (25.9) | 20 (12.7) | 7 (4.4) | 12 (7.6) | 2 (1.3) | 3 (1.9) | 3 (1.9) |
| mEOMs, | 119 (39.3) | 56 (47.1) | 3 (2.5) | 7 (5.9) | 27 (22.7) | 6 (5.0) | 7 (5.9) | 0 (0) | 0 (0) | 6 (5.0) | 7 (5.9) |
| Comitant strabismus, | 26 (8.6) | 0 (0) | 21 (80.8) | 0 (0.0) | 2 (7.7) | 2 (7.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (3.8) |
1 with herpes zoster virus, 1 with Duane retraction syndorme, 2 with chronic progressive external ophthalmoplegia, 1 with conjunctival scar, 1 with high myopia, 1 after surgery of NPC, 1 after surgery of orbital tumor, 3 after intraocular lens implantation. NPC, nasopharyngeal carcinoma; mEOMs, multiple extraocular muscles; sEOM, single extraocular muscle; SES, sagging eye syndrome; TAO, Thyroid associated ophthalmopathy.
Characteristics of patients with paralytic strabismus with sEOM involved.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| No. of patients | 86 | 41 | 18 | 8 | 5 |
| Sex, male/female | 54/32 | 33/8 | 12/6 | 7/1 | 3/2 |
| Age, years | 42.3 ± 14.2 (1–70) | 46.3 ± 16.5 (20–80) | 44.7 ± 21.2 (14–85) | 42.9 ± 20.4 (2–63) | 47.8 ± 17.4 (18–63) |
| Duration, months | 7.9 ± 19.8 (0.1–120) | 19.0 ± 35.8 (0.1–120) | 17.6 ± 49.8 (0.1–216) | 2.5 ± 1.8 (0.4–6) | 2.7 ± 2.1 (0.8–6) |
| Affected eye, R/L/Both | 35/43/8 | 13/16/9 | 9/8/1 | 6/2 | 4/1/0 |
| TAO | 0 (0) | 0 (0) | 1 (5.6) | 0 (0) | 1 (20.0) |
| Idiopathic | 21 (24.5) | 5 (12.2) | 0 (0) | 0 (0) | 0 (0) |
| Microangiopathy | 24 (27.9) | 11 (26.9) | 6 (33.3) | 1 (12.5) | 0 (0) |
| Trauma | 14 (16.3) | 13 (31.7) | 7 (38.9) | 6 (75.0) | 1 (20.0) |
| Intracerebral lesions | 10 (11.6) | 7 (17.1) | 1 (5.6) | 0 (0) | 2 (40.0) |
| Myasthenia gravis | 2 (2.3) | 1 (2.4) | 3 (16.6) | 0 (0) | 1 (20.0) |
| NPC-associated | 11 (12.8) | 1 (2.4) | 0 (0) | 0 (0) | 0 (0) |
| Myositis | 2 (2.3) | 0 (0) | 0 (0) | 1 (12.5) | 0 (0) |
| SES | 2 (2.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Other | 0 (0) | 3 (7.3) | 0 (0) | 0 (0) | 0 (0) |
sEOM, single extraocular muscle; L, left; NPC, nasopharyngeal carcinoma; R, right; TAO, Thyroid associated ophthalmopathy.
Characteristics of individual patients with nasopharyngeal carcinoma associated diplopia.
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 46 | 6 | Radiotherapy | Control | 2 | L | Complete ANP | 1.0/0.8 | ET20 |
| 2 | F | 33 | 60 | Radiotherapy | Control | 12 | R | Partial ANP | 0.6/1.2 | Esophoria |
| 3 | M | 61 | 12 | Radiotherapy | Control | 3 | L | Partial ANP | 0.4/0.4 | ET20 |
| 4 | F | 47 | 60 | Radiotherapy | Control | 3 | R | Partial ANP | 0.25/0.32 | ET25-30 |
| 5 | F | 44 | 84 | Radiotherapy | Control | 2 | L | Complete ANP | 0.01/0.6 | ET25-30 |
| 6 | M | 42 | 36 | Radiotherapy | Control | 0.5 | R | Partial ANP | 0.8/1.2 | ET5-10 |
| 7 | M | 45 | 60 | Radiotherapy | Control | 2 | L | Partial ANP | 1.2/1.2 | ET10-15 |
| 8 | F | 52 | First visit with diplopia | None | None | 0.4 | L | Partial ANP | 1.0/1.0 | ET5-10 |
| 9 | M | 49 | First visit with diplopia | Radiotherapy | Control | 12 | R | Partial ANP | 1.0/1.0 | Esophoria |
| 10 | F | 51 | 156 | Radiotherapy | Control | 6 | Both | Complete ANP | 0.4/0.5 | ET45 |
| 11 | M | 43 | 36 | Radiotherapy | Control | 0.7 | L | Complete ANP | 1.0/1.5 | ET10-15 |
| 12 | M | 62 | 192 | Radiotherapy | Control | 6 | R | SOP | 1.0/1.0 | Orthophoria |
ANP, abducens nerve palsy; F, Female; L, left eye; M, Male; NPC, nasopharyngeal carcinoma; R, right eye; SOP, superior oblique palsy.
Characteristics of patients with paralytic strabismus with multiple EOMs involved.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| No. of patients | 56 | 32 | 8 | 7 | 6 | 10 |
| Sex, male/female | 29/27 | 23/9 | 6/2 | 0/7 | 2/4 | 6/4 |
| Age, years | 50.9 ± 13.5 (16–86) | 45.9 ± 20.8 (5–84) | 29.5 ± 12.8 (10–47) | 37.7 ± 25.6 (4–76) | 45.3 ± 17.6 (24–71) | 42.1 ± 21.0 (15–76) |
| Duration, months | 6 (0.5–360) | 2 (0.1–144) | 4 (0.4–26) | 12 (0.5–72) | 6 (1–24) | 6 (2–180) |
| Affected eye (R/L/Both) | 6/9/41 | 18/11/3 | 5/3/0 | 1/3/3 | 2/3/1 | 2/2/6 |
| Visual acuity (R) | 0.93 ± 0.25 (0.4–1.5) | 0.75 ± 0.39 (0.03–1.5) | 7 cases >0. 8, one >0.3 | 0.4–1.2 | 0.5–1.0 | 0.75 ± 0.41 (0.05–1.0) |
| Visual acuity (L) | 0.88 ± 0.26 (0.3–1.5) | 0.81 ± 0.39 (0.04–1.5) | >0.8 | 0.4–1.2 | 0.5–1.0 | 0.94 ± 0.26 (0.05–1.2) |
| History/details of primary diseases, | 1. History of thyroid: | 1. Trauma,19 (traffic accident1,4; direct injury, 1; orbital trauma,4); | Trauma, 8 (direct injury, 4; and traffic accident, 4) | Pseudophakic eye with hypertension, 1; | Invovled EOMs: 1. IR L | 1. Heavy eye syndrome, 1; |
Both, both eye; EOM, extraocular muscle; L, left eye; R, right eye; TAO, Thyroid associated ophthalmopathy.
Characteristics of comitant strabismus patients.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| No. of patients | 14 | 2 | 1 | 8 | 1 |
| Sex, male/female | 6/8 | 2/0 | 0/1 | 5/3 | 1/0 |
| Age, years | 25.1 ± 16.6 (5–65) | 62, 65 | 39 | 18.6 ± 18.6 (5–59) | 14 |
| Duration, months | 16.1 ± 18 (1–60) | 1, 120 | 12 | 99 ± 206 (2–600) | 2 |
| Cause, | Cerebellopontine angle cholesteatoma, 1; | Idiopathic | Idiopathic | Idiopathic | Cataract surgery with IOL implantation 1 |
AACE, acute acquired comitant esotropia; AACX, acute acquired comitant extrotropia; DVD, dissociated vertical deviation; ET, esotropia; IOL, intraocular lens; IXT, intermittent exotropia.
Characteristics of patients with idiopathic cause.
|
|
|
|
|
|---|---|---|---|
| No. of patients | 26 | 3 | 21 |
| Sex, male/female | 21/5 | 3/0 | 13/8 |
| Age, years | 39.4 ± 12.6 (10–59) | 54, 58, 74 | 27.2 ± 20.1 (5–65) |
| Duration, months | 13.9 ± 48.9 (0.1–252) | 0.1, 1, 5 | 52.5 ± 130.4 (0.3–600) |
| Affected eye (R/L/Both) | 9/14/3 | 1/2/0 | 1/1/19 (alternating) |
| Visual acuity (R) | 1.10 ± 0.28 (0.6–1.5) | 1.0, 1.0, 1.0 | 0.98 ± 0.40 (0.05–1.50) |
| Visual acuity (L) | 1.12 ± 0.30 (0.6–1.5) | 0.9, 1.2, 1.0 | 0.98 ± 0.23 (0.60–1.50) |